Literature DB >> 25499874

A bridge too far? Findings of bridging anticoagulation use and outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Amir Y Shaikh1, David D McManus2.   

Abstract

Entities:  

Keywords:  Editorials; atrial fibrillation; myocardial bridging

Mesh：

Substances：

Year:  2014        PMID： 25499874      PMCID： PMC4415256          DOI： 10.1161/CIRCULATIONAHA.114.014319

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  12 in total

1.  Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.

Authors:  Dhanunjaya Lakkireddy; Yeruva Madhu Reddy; Luigi Di Biase; Subba Reddy Vanga; Pasquale Santangeli; Vijay Swarup; Rhea Pimentel; Moussa C Mansour; Andre D'Avila; Javier E Sanchez; J David Burkhardt; Fadi Chalhoub; Prasant Mohanty; James Coffey; Naushad Shaik; George Monir; Vivek Y Reddy; Jeremy Ruskin; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2012-02-01       Impact factor: 24.094

2.  Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  James D Douketis; Alex C Spyropoulos; Frederick A Spencer; Michael Mayr; Amir K Jaffer; Mark H Eckman; Andrew S Dunn; Regina Kunz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.

Authors:  Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

Review 4.  Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy.

Authors:  A C Spyropoulos; J D Douketis; G Gerotziafas; S Kaatz; T L Ortel; S Schulman
Journal:  J Thromb Haemost       Date:  2012-04       Impact factor: 5.824

5.  Pacemaker or defibrillator surgery without interruption of anticoagulation.

Authors:  David H Birnie; Jeff S Healey; George A Wells; Atul Verma; Anthony S Tang; Andrew D Krahn; Christopher S Simpson; Felix Ayala-Paredes; Benoit Coutu; Tiago L L Leiria; Vidal Essebag
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

6.  Predictors of major bleeding in peri-procedural anticoagulation management.

Authors:  A J Tafur; R McBane; W E Wysokinski; S Litin; P Daniels; J Slusser; D Hodge; M G Beckman; J A Heit
Journal:  J Thromb Haemost       Date:  2012-02       Impact factor: 5.824

7.  Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.

Authors:  Luigi Di Biase; J David Burkhardt; Prasant Mohanty; Javier Sanchez; Rodney Horton; G Joseph Gallinghouse; Dhanunjay Lakkireddy; Atul Verma; Yaariv Khaykin; Richard Hongo; Steven Hao; Salwa Beheiry; Gemma Pelargonio; Antonio Dello Russo; Michela Casella; Pietro Santarelli; Pasquale Santangeli; Paul Wang; Amin Al-Ahmad; Dimpi Patel; Sakis Themistoclakis; Aldo Bonso; Antonio Rossillo; Andrea Corrado; Antonio Raviele; Jennifer E Cummings; Robert A Schweikert; William R Lewis; Andrea Natale
Journal:  Circulation       Date:  2010-06-01       Impact factor: 29.690

8.  Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.

Authors:  James D Douketis; Jeff S Healey; Martina Brueckmann; John W Eikelboom; Michael D Ezekowitz; Mandy Fraessdorf; Herbert Noack; Jonas Oldgren; Paul Reilly; Alex C Spyropoulos; Lars Wallentin; Stuart J Connolly
Journal:  Thromb Haemost       Date:  2014-12-04       Impact factor: 5.249

Review 9.  Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.

Authors:  Deborah Siegal; Jovana Yudin; Scott Kaatz; James D Douketis; Wendy Lim; Alex C Spyropoulos
Journal:  Circulation       Date:  2012-08-21       Impact factor: 29.690

Review 10.  Stroke and bleeding risk in atrial fibrillation: navigating the alphabet soup of risk-score acronyms (CHADS2 , CHA2 DS2 -VASc, R2 CHADS2 , HAS-BLED, ATRIA, and more).

Authors:  Mikhail S Dzeshka; Deirdre A Lane; Gregory Y H Lip
Journal:  Clin Cardiol       Date:  2014-08-28       Impact factor: 2.882
View more
  3 in total

1.  Practice Patterns and Outcomes Associated With Use of Anticoagulation Among Patients With Atrial Fibrillation During Sepsis.

Authors:  Allan J Walkey; Emily K Quinn; Michael R Winter; David D McManus; Emelia J Benjamin
Journal:  JAMA Cardiol       Date:  2016-09-01       Impact factor: 14.676

Review 2.  Effects of antithrombotic therapy on bleeding after endoscopic sphincterotomy: A systematic review and meta-analysis.

Authors:  Gang Huang; Feng-Yu Tian; Wen An; Li-Si Ai; Yan-Bo Yu
Journal:  Endosc Int Open       Date:  2022-06-10

Review 3.  [Platelet aggregation inhibitors and anticoagulants during ophthalmic interventions].

Authors:  N Feltgen; H Hoerauf; W Noske; A Hager; J Koscielny
Journal:  Ophthalmologe       Date:  2016-12       Impact factor: 1.059
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.